DBV Technologies SA (DBVT) Stock Price, Quote, News & History

DBVTNASDAQ
$16.28
-0.47-2.81%
At close: Jun 17, 5:00 PM EST
$16.79
0.513.13%
After Hours: 9:30 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-150.58M
Investing Cash Flow (TTM)
-1.27M
Financing Cash Flow (TTM)
365.08M
Free Cash Flow (TTM)
-151.52M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
213.13M

Analyst Trends and Forecast

1
Mar
1
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$790.08M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
4.76
Earnings Yield % (TTM)
-26.88%
Earnings Yield % (FWD)
-2.87%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$3.51

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$229.20M
Debt to Equity
0.03
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$16.81
Close
$16.28
Volume / Avg.
225.08K / 236.00K
Day Range
$15.94 - $16.94
52 Wk Range
8.50 - 26.19
Market Cap
$993.74M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
38
Short Interest
2.82%
Days to Cover
5.9

About

Sector
Health Care
Industry
Biotechnology
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EP...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy DBV Technologies (DBVT) stock?

A

You can purchase shares of DBV Technologies (NASDAQ:DBVT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are DBV Technologies (DBVT) competitors?

A

There are no as such competitors for DBV Technologies.

Q

What is the forecast, or price target, for DBV Technologies (DBVT) stock?

A

DBV Technologies has a consensus price target of $26.43.

Q

What is the current price for DBV Technologies (DBVT)?

A

The stock price for DBV Technologies (NASDAQ: DBVT) is $16.79 last updated June 17, 2026 at 9:30 AM EDT.

Q

Does DBV Technologies (DBVT) pay a dividend?

A

There are no upcoming dividends for DBV Technologies.

Q

When is DBV Technologies (NASDAQ:DBVT) reporting earnings?

A

DBV Technologies does not have any upcoming earnings scheduled.

Q

Is DBV Technologies (DBVT) going to split?

A

There is no upcoming split for DBV Technologies.

Q

What sector and industry does DBV Technologies (DBVT) operate in?

A

DBV Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.